Evidence mapPaperPMID 42262012Full record

ArticleJournal of diabetes investigation2026

NAA10 and BTRC drive CREBRF degradation in endoplasmic reticulum stress and renal tubular injury.

Sitian Fang, Jing Ning, Jinjing Huang, Yanxia Chen

Abstract read
In one paragraph

Article in Journal of diabetes investigation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Sitian FangDepartment of Nephrology, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
Jing NingDepartment of Nephrology, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
Jinjing HuangDepartment of Nephrology, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
Yanxia ChenDepartment of Nephrology, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.ORCID https://orcid.org/0009-0009-2790-4396

Funding

National Natural Science Foundation of China 82260152
6 · The paper itself

Abstract

backgroundDiabetic kidney disease (DKD) is a frequent complication associated with diabetes. CREBRF was reported to be closely associated with endoplasmic reticulum stress. However, the upstream regulatory mechanism by which CREBRF modulates endoplasmic reticulum stress in DKD renal tubular injury is unknown.

methodsHK-2 cells were treated with high glucose to construct a cellular model of DKD. C57BL/6J mice were injected intraperitoneally with streptozotocin (STZ) to construct an animal model of DKD. Co-IP was employed to assess the interactions between BTRC or NAA10 and CREBRF, as well as the levels of CREBRF acetylation and ubiquitination. Flow cytometry, EdU, and CCK-8 were used to detect apoptosis and proliferation. HE and PAS were performed to test renal histopathological changes. The expression of the above factors and endoplasmic reticulum stress-related proteins was detected by western blot.

resultsCREBRF was downregulated in DKD, and overexpression of CREBRF inhibited endoplasmic reticulum stress to alleviate high glucose-induced renal tubular injury. Additionally, NAA10 promoted acetylation of CREBRF, which facilitated BTRC-mediated ubiquitination and degradation of CREBRF. Finally, NAA10 inhibited CREBRF to promote endoplasmic reticulum stress in high glucose-induced renal tubules.

conclusionNAA10 promoted acetylation of CREBRF, which facilitated ubiquitination and degradation of CREBRF by BTRC, leading to activation of endoplasmic reticulum stress and exacerbation of renal tubular injury in DKD.

Indexed as

Diabetes Mellitus, ExperimentalDiabetic NephropathiesEndoplasmic Reticulum StressKidney TubulesN-Terminal Acetyltransferase AN-Terminal Acetyltransferase EAnimalsApoptosisCell LineGlucoseHumansMaleMiceMice, Inbred C57BLUbiquitinationGlucoseN-Terminal Acetyltransferase AN-Terminal Acetyltransferase EBTRCCREBRFDiabetic kidney disease

Identifiers

PMID42262012
PMCPMC13399122

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.